Israel's Neuronix offers new Alzheimer's treatment

By Tova Cohen | Reuters – 4 hrs ago

TEL AVIV (Reuters) - Israel-based Neuronix, which has developed a non-invasive medical device to help to treat Alzheimer's disease, expects the system to be approved by the U.S. Food & Drug Administration in late 2014.

The device, which combines electromagnetic stimulation with computer-based cognitive training, is already approved for use in Europe, Israel and several Asian countries. In Singapore it is approved for clinical trial use and the application for registration of the product is still under evaluation.

"You stimulate the brain on a biological level as well as on a cognitive level," Neuronix CEO Eyal Baror told Reuters, saying this double approach created longer-lasting benefits.